Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dry-type immunofluorescence chromatography influenza A/B virus antigen detection kit

An influenza B virus and immunofluorescence technology, which is applied in the field of medical detection and immune analysis, can solve the problems of long detection time, high detection cost, missed detection, etc., shorten the detection window period, reduce the detection limit, and improve stability Effect

Pending Publication Date: 2021-11-09
山东康华生物医疗科技股份有限公司 +1
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, the RT-PCR method is the preferred diagnostic method with the highest accuracy, but its disadvantages are high detection cost, long detection time, independent requirements for different reaction conditions in the laboratory, and the need for professionals to operate through equipment, which has certain limitations. is not suitable for large-scale detection applications; the ELISA method takes into account both speed and accuracy, and is a classic method in hospital laboratory departments and disease control system laboratories; colloidal gold method is the fastest, simple and easy, and is suitable for general screening, but The sensitivity of gold detection is low, often resulting in missed detection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dry-type immunofluorescence chromatography influenza A/B virus antigen detection kit
  • Dry-type immunofluorescence chromatography influenza A/B virus antigen detection kit
  • Dry-type immunofluorescence chromatography influenza A/B virus antigen detection kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Such as Figures 1 to 3 As shown, the present invention relates to a dry type immunofluorescence chromatography type A / type B influenza virus antigen detection kit, comprising a detection card, a detection chip and a detection buffer; the detection card comprises a lower cover 1, an upper cover 2 and reagents The lower cover 1 and the upper cover 2 are snap-connected to each other, and a housing cavity is formed between the lower cover 1 and the upper cover 2, the reagent strips are located in the housing cavity, and the upper cover 2 is provided with a sample injection hole 10 and a detection window 11.

[0039] The reagent strip includes absorbent paper 6, nitrocellulose membrane 5, binding pad 4 and sample pad 3, the absorbent paper 6 is located at one end of the nitrocellulose membrane 5, the sample pad 3 is located at the other end of the nitrocellulose membrane 5, and the binding pad 4 is located at the other end of the nitrocellulose membrane 5. Between the sampl...

Embodiment 2

[0042] A dry immunofluorescence chromatography type A / B influenza virus antigen detection kit, including a detection card, a detection chip and a detection buffer; the detection buffer is 10mM PBS+2wt%BSA+0.02wt%casein+0.3 wt% S9+0.5wt% PC300; the detection card includes reagent strips, and the reagent strips include absorbent paper, nitrocellulose membrane, binding pads and sample pads;

[0043] The nitrocellulose membrane is sequentially coated with quality control line C, detection T1 line and detection T2 line;

[0044] The quality control C line is coated with goat anti-mouse antibody at a concentration of 0.1mg / ml. The goat anti-mouse antibody is diluted with 3wt% sucrose in PBS buffer. After the goat anti-mouse antibody is completely dry, spray 3wt on the quality control C line % sucrose PBS buffer to increase quality control stability; the detection T1 line is coated with a mouse anti-human influenza A virus monoclonal antibody with a concentration of 1.5mg / ml, and the...

Embodiment 3

[0073] A dry immunofluorescence chromatography type A / type B influenza virus antigen detection kit, comprising a detection card, a detection chip and a detection buffer; the detection card comprises a reagent strip, and the reagent strip comprises absorbent paper, nitrocellulose Plain film, binding pad and sample pad; the nitrocellulose membrane is coated with quality control line C, detection T1 line and detection T2 line in sequence; the solid phase of the binding pad is marked with 0.1-0.5 mg / ml fluorescent substance The fluorescent antibody formed by mouse anti-human influenza A / B virus monoclonal antibody; the detection buffer is 10mM PBS+0.5wt%BSA+0.05wt%casein+0.5wt%S9+0.5wt%PC300.

[0074] Further, the fluorescent substance labeling process includes the following steps:

[0075] (1) Place the weighed 1.066g MES in a volumetric flask, add double distilled water to dissolve and adjust the volume to 100mL, prepare 50mM MES, and adjust the pH to 5.8; take the prepared MES ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of medical detection and immunoassay, and relates to a dry-type immunofluorescence chromatography influenza A / B virus antigen detection kit, which comprises a detection card, a detection chip and a detection buffer solution, wherein the detection card comprises a reagent strip, wherein the reagent strip comprises absorbent paper, a nitrocellulose membrane, a combination pad and a sample pad; the nitrocellulose membrane is sequentially coated with a quality control line C, a detection line T1 and a detection line T2; a fluorescent antibody formed by a mouse anti-human influenza A / B virus monoclonal antibody marked by a fluorescent substance is solid-phase on the combination pad, so that the influenza A / B virus antigen can be simply, quickly and accurately detected. The influenza virus antigen in a sample is detected by adopting an immunofluorescence double-antibody sandwich method. Compared with the prior art, the kit is simpler and more convenient to operate, saves manpower and material resources, is high in sensitivity and does not need to be operated by professionals. A detection result can be directly obtained through a fluorescence immunoassay quantitative analyzer; the kit is suitable for medical units at all levels, is easy to popularize and has wide applicability.

Description

technical field [0001] The invention relates to the technical field of medical detection and immune analysis, in particular to a dry immunofluorescence chromatography type A / B influenza virus antigen detection kit. Background technique [0002] Influenza viruses are divided into three types: A, B, and C. Type A is the most threatening, followed by Type B. According to the antigenicity of hemagglutinin (HA) and neuraminidase (NA) proteins, influenza A virus can be divided into 15 H subtypes (H1-H15) and 9 N subtypes (N1-N9) . Because the nucleic acid sequence encoding HA or NA is prone to mutations, resulting in changes in the antigenic epitopes of HA or NA, this antigenic change makes the original specific immunity of the population invalid, so influenza A viruses often cause large-scale Even a worldwide flu epidemic. [0003] Influenza virus is a kind of upper respiratory tract infection virus with extremely high morbidity rate, which can reach 80-90% of the population w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/577G01N33/569G01N33/558G01N33/543G01N33/533
CPCG01N33/577G01N33/56983G01N33/558G01N33/54313G01N33/533G01N2469/10G01N2333/11
Inventor 杨金红侯万乐杨帆段存英杨致亭
Owner 山东康华生物医疗科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products